Testing safety of multiple EO2002 eye drops for corneal swelling
Treatments studied
Part of Eyes & vision, Genetic & congenital clinical trials.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a natural lens or a lens implant, with the lens in the “bag” or a specific place called the sulcus
- Have corneal swelling (corneal edema) from inner-corneal dysfunction, such as Fuchs’ corneal dystrophy or bullous keratopathy
- Not have other cornea problems besides the study condition
- Not have had certain recent or complex eye surgeries (like laser/scarring procedures on the eye, vitrectomy, or cornea transplant types) in the past few months
- Your eye pressure must be within a safe range (not too high and not too low)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This trial tests a new treatment for people with corneal swelling that needs surgery. It helps replace the inner layer of the cornea to improve vision.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
Hear when a new Corneal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.